| Chapter title |
Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities
|
|---|---|
| Chapter number | 6 |
| Book title |
Druggable Lipid Signaling Pathways
|
| Published by |
Springer, Cham, September 2020
|
| DOI | 10.1007/978-3-030-50621-6_6 |
| Pubmed ID | |
| Book ISBNs |
978-3-03-050620-9, 978-3-03-050621-6
|
| Authors |
Victoria A. Blaho, Blaho, Victoria A. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 28 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 7 | 25% |
| Student > Ph. D. Student | 3 | 11% |
| Student > Master | 2 | 7% |
| Student > Bachelor | 2 | 7% |
| Other | 1 | 4% |
| Other | 2 | 7% |
| Unknown | 11 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 21% |
| Biochemistry, Genetics and Molecular Biology | 3 | 11% |
| Neuroscience | 3 | 11% |
| Business, Management and Accounting | 1 | 4% |
| Immunology and Microbiology | 1 | 4% |
| Other | 3 | 11% |
| Unknown | 11 | 39% |